Tau5i did not significantly delay hindlimb paralysis, but there was a trend toward significance (8% delay).
← all excerpts
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes.
1
—
—